Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by Pandoraon Jul 01, 2024 8:22pm
94 Views
Post# 36113732

RE:RE:RE:RE:RE:RE:New all time low at 0.04 cad?

RE:RE:RE:RE:RE:RE:New all time low at 0.04 cad?
Turtle4 wrote: Insiders often buy when the share price has fallen so sharply. On the one hand to exude confidence, or simply to make good money if they are convinced that things will go up again. Unfortunately, neither is the case here...
And I don't believe that insider information prohibits them from trading. Abbvie will probably only let you know after the official release.


And I still wonder why Abbvie leaves the Sirona/TF Chem product sitting on the shelf and not releasing it into the market.
Are they, in effect, controlling the market for their existing products until such time as they feel it will be a more opportune time to finally put the new product into the marketplace. i.e. they keep making money on existing product while we as shareowners have to sit back and say "what's the hold up?"

Can't understand why the skin lightening product never went anywhere after getting very good reviews?
<< Previous
Bullboard Posts
Next >>